PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2010 | 70 | 2 |

Tytuł artykułu

The review of most frequently occurring medical disorders related to aetiology of autism and the methods of treatment

Warianty tytułu

Języki publikacji

EN

Abstrakty

EN
The medical understanding of autism has changed since it was first defined by Kanner. Nowadays medicine identifies many medical abnormalities and diseases, which may underline or aggravate the cognitive aspect, behavioural issues and general health in autists. This includes chronic inflammation of gastrointestinal tract, dysbiosis, maldigestion, malabsorption, malnutrition, food intolerance, allergies, chronic viral, fungal and bacterial infections, impaired kidney function, impaired detoxification of endo- and exotoxins, disorders of metal ion transportation. Treatment of the above mentioned conditions combined with improving detoxification mechanisms, followed by a special diet and individually customized supplementation of nutritional deficiencies may lead to the improvement of the functioning of these patients, changing their level of functioning and self-dependence. The aim of this paper is to present medical problems of children with autism which may be identified and treated by general practitioners as a review of current medical papers related to Autism Spectrum Disorder, in the context of author’s professional experience, based on the medical cases from author’s practice.

Słowa kluczowe

Wydawca

-

Rocznik

Tom

70

Numer

2

Opis fizyczny

p.141-146,ref.

Twórcy

  • Foundation for the Development of Integrative Medicine, Piaseczno, Poland
  • Breakspear Medical Hospital Hertfordshire House, Wood Lane Hemel Hempstead, U.K.
  • Pharmacology Department, Institute of Physical Chemistry, Medical University of Warsaw, Warsaw, Poland

Bibliografia

  • Afzal N, Murch S, Thirrupathy K, Berger L, Fagbemi A, Heuschkel R (2003) Constipation with acquired megarec- tum in children with autism. Pediatrics 112: 939-942.
  • Aschner M, Syversen T, Souza DO, Rocha JB (2006) Metallothioneins: mercury species-specific induction and their potential role in attenuating neurotoxicity. Exp Biol Med (Maywood) 231: 1468-1473.
  • Bettelheim B (1967) The empty fortress: infantile autism and the birth of the self. The Free Press, A division of Simon and Schuster Inc, New York, NY, USA. Christison GW, Ivany K (2006) Elimination diets in autism spectrum disorders: any wheat amidst the chaff? J Dev Behav Pediatr 27: S162-S171.
  • Clark-Taylor T, Clark-Taylor BE (2004) Is autism a disorder of fatty acid metabolism? Possible dysfunction of mito­chondrial beta-oxidation by long chain acyl-CoA dehy­drogenase. Med Hypotheses 62: 970-975.
  • Cohen BI (1998) Possible connection between autism, nar­colepsy and multiple sclerosis. Autism 2: 425-427.
  • Cohen BI (2006) Ammonia (NH3), nitric oxide (NO) and nitrous oxide (N2O) - the connection with infantile autism. Autism 10: 221-223.
  • Cone M (2009) Autism epidemic not caused by shifts in diagnoses; environmental factors likely. Environmental Health News. [Avaiable at: http://www.environmental- healthnews.org/ehs/news/autism-and-environment].
  • Davies YK, Cox KM, Abdullah BA, Safta A, Terry AB, Cox KL (2008) Long-term treatment of primary sclerosing cho­langitis in children with oral vancomycin: an immunomod- ulating antibiotic. J Pediatr Gastroenterol Nutr 47: 61-7.
  • Filipek PA, Accardo PJ, Baranek GT, Cook EH Jr, Dawson G, Gordon B, Gravel JS, Johnson CP, Kallen RJ, Levy SE, Minshew NJ, Ozonoff S, Prizant BM, Rapin I, Rogers SJ, Stone WL, Teplin S, Tuchman RF, Volkmar FR (1999) The screening and diagnosis of autistic spectrum disor­ders. J Autism Dev Disord 29: 439-484.
  • Filipek PA, Juranek J, Nguyen MT, Cummings C, Gargus JJ (2004) Relative carnitine deficiency in autism. J Autism Dev Disord 34: 615-23.
  • Finegold SM, Molitoris D, Song Y, Liu C, Vaisanen ML, Bolte E, McTeague M, Sandler R, Wexler H, Marlowe EM, Collins MD, Lawson PA, Summanen P, Baysallar M, Tomzynski TJ, Read E, Johnson E, Rolfe R, Nasir P, Shah H, Haake DA, Manning P, Kaul A (2002) Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis 35: S6-S16.
  • Ghaziuddin M, Al-Khouri I, Ghaziuddin N (2002) Autistic symptoms following herpes encephalitis. Eur Child Adolesc Psychiatry 11: 142-146.
  • Gillberg C (1986) Onset at age 14 of a typical autistic syn­drome. A case report of a girl with herpes simplex encephalitis. J Autism Dev Disord 16: 369-75.
  • Gillberg IC (1991) Autistic syndrome with onset at age 31 years: herpes encephalitis as a possible model for child­hood autism. Dev Med Child Neurol 33: 920-924. Gorker I, Tuzun U (2005) Autistic-like findings associated with a urea cycle disorder in a 4-year-old girl. J Psychiatry Neurosci 30: 133-5.
  • Holtzman D (2008) Autistic spectrum disorders and mito­chondrial encephalopathies. Acta Paediatr 97: 859-860.
  • Horvath K, Papadimitriou JC, Rabsztyn A, Drachenberg C, Tildon JT (1999) Gastrointestinal abnormalities in chil­dren with autistic disorder. J Pediatr 135: 559-563.
  • Horvath K, Perman JA (2002) Autism and gastrointestinal symptoms. Curr Gastroenterol Rep 4: 251-258.
  • Johnson CP, Myers SM, American Academy of Pediatrics Council on Children with Disabilities (2007) Identification and evaluation of children with autism spectrum disor­ders. Pediatrics 120: 1183-1215.
  • Kanner L, Eisenberg L (1956) Childhood schizophrenia; symposium, 1955. VI. Early infantile autism, 1943-1955. Am J Orthopsychiatry 26: 556-566.
  • Knapp M, Romeo R, Beecham J (2009) Economic cost of autism in the UK. Autism 13: 317-336.
  • Kugathasan S (2001) Pediatric inflammatory bowel disease: clinical and therapeutic aspects. Curr Opin Gastroenterol 17: 350-5.
  • Nicolson GL, Gan R, Nicolson NL, Haier J (2007) Evidence for Mycoplasma ssp., Chlamydia pneunomiae, and human herpes virus-6 coinfections in the blood of patients with autistic spectrum disorders. J Neurosci Res 85: 1143-1148.
  • Palmer RF, Blanchard S, Stein Z, Mandell D, Miller C (2006) Environmental mercury release, special education rates, and autism disorder: an ecological study of Texas. Health Place 12: 203-209.
  • Palmer RF, Blanchard S, Wood R (2009) Proximity to point sources of environmental mercury release as a predictor of autism prevalence. Health Place 15: 18-24.
  • Parracho HM, Bingham MO, Gibson GR, McCartney AL (2005) Differences between the gut microflora of children with autistic spectrum disorders and that of healthy chil­dren. J Med Microbiol 54: 987-991.
  • Plioplys AV, Greaves A. Yoshida W (1989) Anti-CNS anti­bodies in childhood neurologic diseases. Neuropediatrics 20: 93-102.
  • Poling JS, Frye RE, Shoffner J, Zimmerman AW (2006) Developmental regression and mitochondrial dysfunction in a child with autism. J Child Neurol 21: 170-172.
  • Rimland B (1964) Infantile autism: the syndrome and its implications for a neural theory of behavior. Prentice Hall, New York: Appleton-Century-Crafts, NY, USA.
  • Rossignol DA, Bradstreet JJ (2008) Evidence of mitochon­drial dysfunction in autism and implications for treat­ment. A J Biochem Biotechnol 4: 208-217.
  • Sandler RH, Finegold SM, Bolte ER, Buchanan CP, Maxwell AP, Vaisanen ML, Nelson MN, Wexler HM (2000) Short- term benefit from oral vancomycin treatment of regres­sive-onset autism. J Child Neurol 15: 429-35.
  • Singh VK, Lin SX, Yang VC (1998) Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism. Clin Immunol Immunopathol 89: 105-108.
  • Song Y, Liu C, Finegold SM (2004) Real-time PCR quanti­tation of Clostridia in feces of autistic children. Appl Environ Microbiol 70: 6459-6465.
  • Vojdani A, Campbell AW, Anyanwu E, Kashanian A, Bock K, Vojdani E (2002) Antibodies to neuron-specific anti­gens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneu- moniae and Streptococcus group A. J Neuroimmunol 129: 168-77.
  • Vojdani A, Pangborn JB, Vojdani E, Cooper EL. (2003) Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism. International J Immunopathol Pharmacol 16: 189-199.
  • Vojdani A, O'Bryan T, Green JA, Mccandless J, Woeller KN, Vojdani E, Nourian AA, Cooper EL (2004a) Immune response to dietary proteins, gliadin and cerebellar pep- tides in children with autism. Nutr Neurosci 7: 151-161.
  • Vojdani A, O'Bryan T, Green JA, Mccandless J, Woeller KN, Vojdani E., Nourian AA, Cooper EL (2004b) Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease. Clin Diagn Lab Immunol 11: 515-24.
  • Wakefield AJ (1999) MMR vaccination and autism. Lancet 354: 949-950.
  • Weissman JR, Kelley RI, Bauman ML, Cohen BH, Murray KF, Mitchell RL, Kern RL, Natowicz MR (2008) Mitochondrial disease in autism spectrum disorder patients: a cohort analysis. PLoS ONE 3: e3815.
  • Whelan J (2000) Antibiotics: a possible treatment for regres­sive-onset autism. Drug Discov Today 5: 487-488.
  • Whiteley P, Shattock P (2002) Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention. Expert Opin Ther Targets 6: 175-183.

Uwagi

EN
Rekord w opracowaniu

Typ dokumentu

Bibliografia

Identyfikatory

Identyfikator YADDA

bwmeta1.element.agro-a31c5305-6cde-4109-9d8b-1a1812cf2748
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.